NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email “I look forward to getting a phone call from him because he has my number,” Ontario Premier Doug Ford said of Lourenco Goncalves, president and CEO of Cleveland-Cliffs, which bought Stelco last year. “I’m going to blast him.”Read More